PCR-BASED ENTERIC DISEASE TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL PCR-BASED ENTERIC DISEASE TESTING MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PCR-BASED ENTERIC DISEASE TESTING MARKET

7.1 GLOBAL PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA PCR-BASED ENTERIC DISEASE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 Thermo Fisher Scientific

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Vela Diagnostics

16.3 CorisBioconcept

16.4 Meridian Life Science

16.5 Bio-Rad Laboratories

16.6 Abbott (ALERE)

16.7 bioMerieux SA

16.8 Trinity Biotech

16.9 DiaSorin Molecular

16.10 Etta Healthcare (Ovagene Oncology)

16.11 ExcitePCR (PositiveID Corporation)

16.12 Flow Alliance

16.13 Fluid-Screen

16.14 FluimediX

16.15 Fluxergy

16.16 Focus Diagnostics (DiaSorin Molecular)

16.17 Future Horizon Scientific

16.18 Genalyte

16.19 GeneFluidics

16.20 GenSpeed Biotech

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER